Front page of the New York Times, Sunday, says he's losing his hearing. T'would be a feather in our cap if he was in the second or third cohort and could regain his hearing.
zoos7, got a source on NSCs who went to the same school as Aboody (source is a he) I'll find out what he thinks. Like the fact that they've "oned" in humans and don't have to combine Genvec's delivery with TBX02 in animals. time is money.
Patience, bio. We're now in the king of : cancer, delivering a tumor specific metabolite, SN-38, that is a thousand times more toxic to tumors than what's available. if you are calm, cool, collected, and a long term investor, I'm low on my hundred dollar target...
your anger is understandable. China's lack of economic recovery is a killer. No one thought it would last this long, and shows no sign of ending. things will stink till then.
A company with 31 U.S. patents, 26 more U.S. patents pending, and they just got one, can not be a scam. Read the March 31, 20 F. They might have been financially clumsy in the past, and--who knows--they may still be, but they are legitimate.
you know scads more than I do about this space, but didn't the Government provide some financing to GNVC in the past due to the necessity of the drug? and we have been led to believe they are very much enthused over RSV. Can't they help here, if they love it?
Sentiment: Strong Buy
Hearing is what it is and we'll know soon. The gigantic negative is: they seem to have dramatic improvements in HSV and RSV therapeutic/vaccine and they can't seem to convince anyone. Each should be worth more than a billion a year in revenues. Its increasing my use of Woodford Reserve...but its fun.
they seem to be spread too thin. that's a death knell for nano caps. they should sell 80% (or thereabouts) of one of their two business and with the money, focus even more on the other one.